NFKB1 and pulmonary arterial hypertension: These data support our hypothesis that pathogenic variants in TNIP2 and TRAF2 result in dysregulated NF-κB activation and could drive abnormal cell proliferation in PAH, as illustrated by the response of lung pericytes transfected with the corresponding siRNAs (Figure 3).